Study: Cannabinoids May Treat Newborn Brain Injury Caused by Germinal Matrix Hemorrhage

An important new study published by the National Institute of Health has found that activation of the endocannabinoid system – something donemedcannabis naturally by cannabinoids – can attenuate newborn brain injury caused by germinal matrix hemorrhages, which is one of the most common and devastating cerebrovascular events that affect premature infants.

For the study, researchers investigated the effects of a cannabinoid receptor 2 (CB2R) agonist – meant to mimic the effect of cannabinoids – on young rats with germinal matrix hemorrhages (GMH).

“We demonstrated that activation of CB2R played a key role in attenuating brain edema, neuronal degeneration, microglial accumulation and the phosphorylated extracellular signal-regulated kinase (p-ERK) protein level 24 h following GMH”, says researchers.

Read moreStudy: Cannabinoids May Treat Newborn Brain Injury Caused by Germinal Matrix Hemorrhage

Cannabis May Improve Outcome of Spinal Cord Injury, Finds Study

Activatiospinaln of the body’s cannabinoid receptors – something done naturally by cannabis – can improve the outcome of spinal cord injury, according to a study published in the most recent issue (Volume 595, May, 2015) of the journal Neuroscience Letters.

For the study, researchers “examined whether treatment with.. a selective synthetic cannabinoid receptor (CB1R) agonist, inhibits MMP [matrix metalloproteinase] and improves functional and histological recovery in a mouse spinal cord compression injury model.” According to the study, MPP iactivity “contributes to glial scar formation that inhibits the repair path after spinal cord injury (SCI)”.

Read moreCannabis May Improve Outcome of Spinal Cord Injury, Finds Study

New Study: Cannabis May Treat Autoimmune Diseases, Prevent Graft Rejection

A newflower study being published in the upcoming issue of the Journal of Neuroimmune Pharmacology, and e-published ahead of print by the National Institute of Health, has found that cannabis may have immunosuppressive and anti-inflammatory properties, which may help treat a variety of conditions such as autoimmune diseases and graft rejection.

According to researchers; “This review examines the effects of cannabinoids on immune function, with a focus on effects on T-cells, as well as on resistance to infection. The paper considers the immune modulating capacity of marijuana, of ∆9-THC extracted from the marijuana plant, and synthetic cannabinoids.”

Read moreNew Study: Cannabis May Treat Autoimmune Diseases, Prevent Graft Rejection